InsidersTradesSigma
Follow the 金石亚药 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Industrials sector, 金石亚药 has logged 3 insider filings. Market capitalisation: €3.9bn. The latest transaction was disclosed on 22 September 2022 (Purchase). Among the most active insiders: 魏宝康. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
金石亚药是一家在工业领域运营的公司，专门从事药品制造。该公司在深圳证券交易所上市。